RAD50/MRE11/NBS1 proteins in relation to tumour development and prognosis in patients with microsatellite stable colorectal cancer

Histology and Histopathology

Volumn 23, Issue 12, 2008, Pages 1495-1502

  Gao, Jingfang ^a   Zhang, Hong ^b   Arbman, Gunnar ^c   Sun, Xiao Feng ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF SKÖVDE   (Sweden)

^c Department of Surgery ^*  (Sweden)

Author keywords

Colorectal cancer; MRE11; NBS1; Prognosis; RAD50

Indexed keywords

MRE11 PROTEIN; NIBRIN; PROTEIN MLH1; RAD50 PROTEIN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; MICROSATELLITE DNA; MRE11A PROTEIN, HUMAN; NBN PROTEIN, HUMAN; NUCLEAR PROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; RAD50 PROTEIN, HUMAN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; BIOSYNTHESIS; COLORECTAL TUMOR; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PATHOLOGY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 58149308362     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Angele S., Treilleux I., Bremond A., Taniere P. and Hall J. (2003). Altered expression of DNA double-strand break detection and repair proteins in breast carcinomas. Histopathology 43, 347-353.
2. Assenmacher N. and Hopfner K.P. (2004). MRE11/RAD50/NBS1: complex activities. Chromosoma 113, 157-166.
3. Bender C.F., Sikes M.L., Sullivan R., Huye L.E., Le Beau M.M., Roth D.B., Mirzoeva O.K., Oltz E.M. and Petrini J.H. (2002). Cancer predisposition and haematopoietic failure in Rad50 (S/S) mice. Genes. Dev. 16, 2237-2251.
4. Carney J.P., Maser R.S., Olivares H., Davis E.M., Le Beau M., Yates J.R. 3rd, Hays L., Morgan W.F. and Petrini J.H. (1998). The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 93, 477-486.
5. Emterling A., Wallin A., Arbman G. and Sun X.F. (2004). Clinicopathological significance of microsatellite instability and mutated RIZ in colorectal cancer. Ann. Oncol. 15, 242-246.
6. Evertson S., Wallin A., Arbman G., Rutten S., Emterling A., Zhang H. and Sun X.F. (2003). Microsatellite instability and MBD4 mutation in unselected colorectal cancer. Anticancer Res. 23, 3569-3574.
7. Evertsson S., Bartik Z., Zhang H., Jansson A. and Sun X.F. (1999). Apoptosis in relation to proliferating cell nuclear antigen and Dukes' stage in colorectal adenocarcinoma. Int. J. Oncol. 15, 53-58.
8. Gao J., Zhang H., Arbman G. and Sun X.F. (2008). The different roles of hRAD50 in microsatellite stable and unstable colorectal cancers. Dis. Markers 24, 127-134
9. Giannini G., Ristori E., Cerignoli F., Rinaldi C., Zani M., Viel A., Ottini L., Crescenzi M., Martinotti S., Bignami M., Frati L., Screpanti I. and Gulino A. (2002). Human MRE11 is inactivated in mismatch repair-deficient cancers. EMBO Rep. 3, 248-254.
10. Giannini G., Rinaldi C., Ristori E., Ambrosini M.I., Cerignoli F., Viel A., Bidoli E., Berni S., D'Amati G., Scambia G., Frati L., Screpanti I. and Gulino A. (2004). Mutations of an intronic repeat induce impaired MRE11 expression in primary human cancer with microsatellite instability. Oncogene 23, 2640-2647.
11. Ikenoue T., Togo G., Nagai K., Ijichi H., Kato J., Yamaji Y., Okamoto M., Kato N., Kawabe T., Tanaka A., Matsumura M., Shiratori Y. and Omata M. (2001). Frameshift mutations at mononucleotide repeats in RAD50 recombinational DNA repair gene in colorectal cancers with microsatellite instability. Jpn. J. Cancer Res. 92, 587-591.
12. Kim N.G., Choi Y.R., Baek M.J., Kim Y.H., Kang H., Kim N.K., Min J.S. and Kim H. (2001). Frameshift mutations at coding mononucleotide repeats of the hRAD50 gene in gastrointestinal carcinomas with microsatellite instability. Cancer Res. 61, 36-38.
13. Koh K.H., Kang H.J., Li L.S., Kim N.G., You K.T., Yang E., Kim H., Kim H.J., Yun C.O., Kim K.S. and Kim H. (2005). Impaired nonhomologous end-joining in mismatch repair-deficient colon carcinomas. Lab. Invest. 85, 1130-1138.
14. Jansson A., Arbman G., Zhang H. and Sun X.F. (2003). Combined deficiency of hMLH1, hMSH2, hMSH3 and hMSH6 is an independent prognostic factor in colorectal cancer. Int. J. Oncol. 22, 41-49.
15. Luo G., Yao M.S., Bender C.F., Mills M., Bladl A.R., Bradley A. and Petrini J.H. (1999). Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation. Proc. Natl Acad. Sci. USA 96, 7376-7381.
16. Maga G. and Hubscher U. (2003). Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J. Cell Sci. 116, 3051-3060.
17. Matsutani N., Yokozaki H., Tahara E., Tahara H., Kuniyasu H., Kitadai Y., Haruma K., Chayama K., Tahara E. and Yasui W. (2001). Expression of MRE11 complex (MRE11, RAD50, NBS1) and hRap1 and its relation with telomere regulation, telomerase activity in human gastric carcinomas. Pathobiology 69, 219-224.
18. Paull T.T. and Gellert M. (1999). Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex. Genes Dev. 13, 1276-1288.
19. Stewart G.S., Maser R.S., Stankovic T., Bressan D.A., Kaplan M.I., Jaspers N.G., Raams A., Byrd P.J., Petrini J.H. and Taylor AM. (1999). The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99, 577-587.
20. Sun X.F., Carstensen J.M., Stal O., Zhang H. and Nordenskjold B. (1996). Proliferating cell nuclear antigen (PCNA) in relation to ras, cerbB-2, p53, clinico-pathological variables and prognosis in colorectal adenocarcinoma. Int. J. Cancer. 69, 5-8.
21. Taylor A.M., Groom A. and Byrd P.J. (2004). Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis. DNA Repair 3, 1219-1225.
22. Vamvakas S., Vock E.H. and Lutz W.K. (1997). On the role of DNA double-strand breaks in toxicity and carcinogenesis. Crit. Rev. Toxicol. 27, 155-174.
23. Xiao Y. and Weaver D.T. (1997). Conditional gene targeted deletion by Cre recombinase demonstrates the requirement for the double-strand break repair Mre11 protein in murine embryonic stem cells. Nucleic Acids Res. 25, 2985-2991.
24. Zhu J., Petersen S., Tessarollo L. and Nussenzweig A. (2001). Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice. Curr. Biol. 11, 105-109.